Opus Point Partners Management, LLC historic quarter change: USA Stocks, New
In share positions in stocks (listed in the US), over 7 quarters from 2014-12-31 to 2016-09-30, Opus Point Partners Management, LLC opened 19 positions, added to 60, reduced 54 and sold out of 17.
- Q3 2016: Stock PCRX; Country of operation United States; Class COM; Shares before 0.
- Q3 2016: Stock NBIX; Country of operation United States; Class COM; Shares before 0.
- Q1 2016: Stock PFE; Country of operation United States; Class COM; Shares before 0.
- Q1 2016: Stock RARE; Country of operation United States; Class COM; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1600175), 7 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-18). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM | 0 | 50,000 | +50,000 | $0 | $1,711,000 | +$1,711,000 | 2016-11-14 |
|---|
| Q3 2016 | NBIX
NEUROCRINE BIOSCIENCES INC | United States | COM | 0 | 4,068 | +4,068 | $0 | $206,000 | +$206,000 | 2016-11-14 |
|---|
| Q1 2016 | PFE
PFIZER INC | United States | COM | 0 | 110,000 | +110,000 | $0 | $3,260,000 | +$3,260,000 | 2016-05-16 |
|---|
| Q1 2016 | RARE
ULTRAGENYX PHARMACEUTICAL IN | United States | COM | 0 | 13,500 | +13,500 | $0 | $855,000 | +$855,000 | 2016-05-16 |
|---|
| Q4 2015 | IONS
IONIS PHARMACEUTICALS INC | United States | COM | 0 | 102,459 | +102,459 | $0 | $6,345,000 | +$6,345,000 | 2016-02-16 |
|---|
| Q4 2015 | XNCR
XENCOR INC | United States | COM | 0 | 90,000 | +90,000 | $0 | $1,316,000 | +$1,316,000 | 2016-02-16 |
|---|
| Q4 2015 | BCRX
BIOCRYST PHARMACEUTICALS | United States | COM | 0 | 100,000 | +100,000 | $0 | $1,032,000 | +$1,032,000 | 2016-02-16 |
|---|
| Q4 2015 | MGNX
MACROGENICS INC | United States | COM | 0 | 30,000 | +30,000 | $0 | $929,000 | +$929,000 | 2016-02-16 |
|---|
| Q3 2015 | ALKS
ALKERMES PLC | | SHS | 0 | 86,864 | +86,864 | $0 | $5,096,000 | +$5,096,000 | 2015-11-16 |
|---|
| Q3 2015 | AGIO
AGIOS PHARMACEUTICALS INC | United States | COM | 0 | 46,000 | +46,000 | $0 | $3,247,000 | +$3,247,000 | 2015-11-16 |
|---|
| Q3 2015 | BMY
BRISTOL MYERS SQUIBB CO | United States | COM | 0 | 36,000 | +36,000 | $0 | $2,131,000 | +$2,131,000 | 2015-11-16 |
|---|
| Q3 2015 | MRK
MERCK & CO INC NEW | United States | COM | 0 | 41,000 | +41,000 | $0 | $2,025,000 | +$2,025,000 | 2015-11-16 |
|---|
| Q3 2015 | LAB
FLUIDIGM CORP DEL | United States | COM | 0 | 15,000 | +15,000 | $0 | $122,000 | +$122,000 | 2015-11-16 |
|---|
| Q2 2015 | INFIQ
INFINITY PHARMACEUTICALS INC CMN | United States | COM | 0 | 80,000 | +80,000 | $0 | $876,000 | +$876,000 | 2015-08-14 |
|---|
| Q1 2015 | PCRX
PACIRA PHARMACEUTICALS, INC. CMN | United States | COM | 0 | 34,949 | +34,949 | $0 | $3,105,000 | +$3,105,000 | 2015-05-18 |
|---|
| Q1 2015 | ESPR
ESPERION THERAPEUTICS INC CMN | United States | COM | 0 | 15,000 | +15,000 | $0 | $1,389,000 | +$1,389,000 | 2015-05-18 |
|---|
| Q1 2015 | RARE
ULTRAGENYX PHARMACEUTICAL INC. CMN | United States | COM | 0 | 12,000 | +12,000 | $0 | $745,000 | +$745,000 | 2015-05-18 |
|---|
| Q1 2015 | MGNX
MACROGENICS, INC. CMN | United States | COM | 0 | 15,000 | +15,000 | $0 | $471,000 | +$471,000 | 2015-05-18 |
|---|
| Q1 2015 | OMER
OMEROS CORPORATION CMN | United States | COM | 0 | 20,000 | +20,000 | $0 | $441,000 | +$441,000 | 2015-05-18 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |